June 26, 2025 The Critical Path Institute Podcast: Connecting the Dots with DCC This newest Critical Path Institute® (C-Path) podcast episode provides an in-depth exploration of one of C-Path's core teams...
June 26, 2025 C-Path Q2 2025 Newsletter This year marks a historic milestone for C-Path as we celebrate 20 years of advancing regulatory science...
June 20, 2025 C-Path Launches Global Collaborative to Advance Drug Development for Neonatal Brain Injury C-Path, through its International Neonatal Consortium (INC), is proud to announce the official launch of the Neonatal Brain...
June 20, 2025 C-Path’s T1D Consortium to Release a Clinical Trial Simulation Tool for New-Onset Trial Design C-Path's Type 1 Diabetes Consortium today announced the release of a pilot version of their regulatory-grade new-onset clinical...
June 18, 2025 C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes C-Path's Translational Therapeutics Accelerator (TRxA) proudly announced a $250,000 grant...
June 17, 2025-June 18, 2025 Workshop: 21st Century Trials in New-Onset T1D Critical Path Institute’s Type 1 Diabetes consortium held a virtual workshop...
June 17, 2025 Honoring Progress and Hope Amidst Alzheimer’s and Brain Awareness Month Each June, we come together to recognize Alzheimer’s and Brain Awareness Month—a time to raise visibility for the 55 million..
June 16, 2025 New Paper in Nature Reviews Drug Discovery Highlights How to Maximize the Regulatory Impact of Consortium-Based Projects The paper, by authors from IHI and the Critical Path Institute, highlights the importance of a structured, strategic...